Synchrotron XRPD

Pharmaceutical formulations: Excelsus quantifies amorphous drug forms

Using state-of-the-art synchrotron X-ray powder diffraction at the Paul Scherrer Institute (PSI) and the pair distribution function (PDF) technique, Excelsus...

More details More details

From academia to industry: successful recruiting at PARK INNOVAARE

Excelsus Structural Solutions (Swiss) AG has long been planning to enlarge its team. But finding the right people is not at all easy for this highly specialized...

More details

Pharmaceutical mixtures: Excelsus achieves an unprecedented level of detection

X-Ray Powder Diffraction (XRPD) is a powerful technique that exploits the interaction between X-rays and matter to study the structural and microstructural...

More details

Dr. Fabia Gozzo: "Our customers come from all over the world."

Interview with Dr. Fabia Gozzo, Founder and CEO of Excelsus Structural Solutions (Swiss) AG Excelsus Structural Solutions (Swiss) AG, Villigen, a spin-off...

More details

PARK INNOVAARE welcomes Excelsus Structural Solutions

Excelsus Structural Solutions (Swiss) AG, Villigen, a spin-off company of the Paul Scherrer Institute (PSI), has moved to PARK INNOVAARE’s deliveryLAB....

More details
Subscribe to Synchrotron XRPD